drugset / Trial / NCT06085937
Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
NaSingle-groupOpen-labelTreatment
Summary
There is currently no readily available pharmacologic intervention for suicidal ideation, a true psychiatric emergency, in the Emergency Department (ED). Investigators aim to trial low-dose, intravenous ketamine, a drug with well-established use in treatment-resistant depression, for patients who present to the ED with suicidal ideation.
Timeline
- Start
- 2024-05-01
- Primary completion
- 2026-04
- Completion
- 2027-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.2 mg/kg | Intravenous |